Leukemia Cell Surface Antigen Modulation Induced By Dual CD19/CD20 Chimeric Antigen Receptor (CAR)-T Cells

被引：0
|
作者：
Schneider, Dina [1 ]
Xiong, Ying [1 ]
Wu, Darong [1 ]
Nolle, Volker [2 ]
Schmitz, Sarah [2 ]
Kaiser, Andrew [2 ]
Dropulic, Boro [3 ]
Orentas, Rimas [3 ]
机构：
[1] Miltenyi Biotec Co, Lentigen Technol Inc, Translat Res & Dev, Gaithersburg, MD USA
[2] Miltenyi Biotec GmbH, Bergisch Gladbach, Germany
[3] Miltenyi Biotec Co, Lentigen Technol Inc, Gaithersburg, MD USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2017年 / 23卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
273
引用
收藏
页码：S209 / S210
页数：2
相关论文
共 50 条
  • [31] Phase I Dose-Escalation Trial of CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) T-Cells for the Treatment of Relapsed or Refractory B-Cell Lymphomas and Chronic Lymphocytic Leukemia
    Ghafouri, Sanaz
    Walthers, Christopher
    Roshandell, Mobina
    Ji, Brenda
    Trent, Jacqueline
    Chen, Jia Ming
    Naparstek, Jacob
    Mead, Monica
    Timmerman, John M.
    Chen, Yvonne
    Larson, Sarah
    BLOOD, 2020, 136
  • [32] Chimeric antigen receptor-modified T cells: CD19 and the road beyond
    Salter, Alexander I.
    Pont, Margot J.
    Riddell, Stanley R.
    BLOOD, 2018, 131 (24) : 2621 - 2629
  • [33] Development of a compact bidirectional promoter-driven dual chimeric antigen receptor (CAR) construct targeting CD19 and CD20 in the Sleeping Beauty (SB) transposon system
    Khaniya, Asmita
    Rad, S. M. Ali Hossieni
    Halpin, Josh
    Tawinwung, Supannikar
    McLellan, Alexander
    Suppipat, Koramit
    Hirankarn, Nattiya
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (04)
  • [34] PIGGYBAT TRANSPOSASE FOR THE GENERATION OF CD19 SPECIFIC CHIMERIC ANTIGEN RECEPTOR T CELLS
    Sutrave, G.
    Gowrishankar, K.
    Gottlieb, D.
    Micklethwaite, K.
    CYTOTHERAPY, 2019, 21 (05) : S17 - S17
  • [35] Transfusion Support for CD19 Chimeric Antigen Receptor T-Cell Therapy
    Saifee, Nabiha H.
    Cottrell, Ryan
    Kuciel, Ariel
    Gardner, Rebecca A.
    Delaney, Meghan
    TRANSFUSION, 2019, 59 : 194A - 195A
  • [36] Closed-system manufacturing of CD19 and dual-targeted CD20/19 chimeric antigen receptor T cells using the CliniMACS Prodigy device at an academic medical center
    Zhu, Fenlu
    Shah, Nirav
    Xu, Huiqing
    Schneider, Dina
    Orentas, Rimas
    Dropulic, Boro
    Hari, Parameswaran
    Keever-Taylor, Carolyn A.
    CYTOTHERAPY, 2018, 20 (03) : 394 - 406
  • [37] A New Frontier: CD19 Chimeric Antigen Receptor T-Cell Therapy
    Alkureishi, Lolita Alcocer
    Hageman, Joseph R.
    PEDIATRIC ANNALS, 2024, 53 (05): : e157 - e158
  • [38] T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells (vol 4, pg 498, 2016)
    Zah, Eugenia
    Lin, Meng-Yin
    Silva-Benedict, Anne
    Jensen, Michael C.
    Chen, Yvonne Y.
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (07) : 639 - 641
  • [39] Targeting of CD19 By Tafasitamab Does Not Impair CD19 Directed Chimeric Antigen Receptor T Cell Activity in Vitro
    Horvei, Paulina
    Sakemura, Reona
    Cox, Michelle J.
    Roman, Claudia Manriquez
    Schick, Kendall J.
    Ruff, Michael W.
    Hefazi, Mehrdad
    Tapper, Erin E.
    Hansen, Michael J.
    Schanzer, Juergen
    Endell, Jan
    Kay, Neil E.
    Nowakowski, Grzegorz S.
    Kenderian, Saad S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S223 - S224
  • [40] CD19 chimeric antigen receptor-T cells in B-cell leukemia and lymphoma: current status and perspectives
    Mohamad Mohty
    Jordan Gautier
    Florent Malard
    Mahmoud Aljurf
    Ali Bazarbachi
    Christian Chabannon
    Mohamed A. Kharfan-Dabaja
    Bipin N. Savani
    He Huang
    Saad Kenderian
    Arnon Nagler
    Miguel-Angel Perales
    Leukemia, 2019, 33 : 2767 - 2778
12345